Raynaud’s syndrome revealing hypereosinophilic syndrome
##plugins.themes.academic_pro.article.main##
##plugins.themes.academic_pro.article.details##
References
- Chusid MJ, Dale DC, West BC et Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine 1975; 54(1): 1-27.
- Simon HU, Rothenberg ME, Bochner BS, Weller PS, Wardlaw AJ, Wechsler ME et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 2010;126:45-9
- Ogbogu PU, Bochner BS, Butterfield JH, Gleich GJ, Huss-Marp J, Kahn JE et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009; 124:1319-25 (e3)
- Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS. Eosinophilic cationic granule proteins impair thrombomodulin function. J Clin Invest 1993:91:1721-30
- Narayan S, Ezughah F, Standen GR, Pawade J, Kennedy CT. Idiopathic hypereosinophilic syndrome associated with cutaneous infarction and deep venous thrombosis. Br J Dermato. 2003; 148:817-820
- Rohrbach MS, Wheathley CL, Slifman NR, Gleich GJ. Activation of platelets by eosinophilic granule proteins. J Exp Med.1990;172:1271-4
- Wassom DL, Loegering DA, Solley GO, et al. Elevated serum levels of the eosinophilic granule major basic protein in patients with eosinophilia. J Clin Invest.1981;67:651-661
- Jang KA, Lim YS, Choi JH, Sung KJ,, Moon KC, Koh JK. Hypereosinophilic syndrome presenting as cutaneous necrotizing eosinophilic vasculitis and Raynaud's phenomenon complicated by digital gangrene. Br J Dermatol 2000; 143:641-4
- Liapis H, Ho AK, Brown D, Mindel G, Gleich G. Thrombotic microangiopathy associated with the hypereosinophilic syndrome. Kidney Int.2005;67:1806-1811
- Gauchat JF, Henchoz S, Fattah D, et al. CD40 ligand is functionally expressed on human eosinophils. Eur J immunol. 1995;25:863-5
- Kim SH, Kim TB, Yun YS, Shin JI, Oh IY, Sir JJ et al. Hypereosinophilia presenting as eosinophilic vasculitis and multiple peripheral artery occlusions without organ involvement. J Korean Med Sci.2005;20:677-9
- Terrier B, Piette AM, Kerob D, Cordoliani F, Tancrède E, Hamidou L et al. Superficila venous thrombophlebitis as the initial manifestation of hypereosinophilic syndrome. Arch Dermatol. 2006; 142:1606-10
- Ohtani T, Okamoto K, Kaminaka C, Kishi T, Sakurane M, Yamamoto Y. Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS). Eur J Dermatol. 2004; 14:168- 71
- Oppliger R, Gay-Croisier F, Dayer E, Hauser C. Digital necrosis in a patient with hypereosinophilic syndrome in the absence of cutaneous vasculitis. Br J Dermatol. 2001;144:1087-9
- Hachulla E, Hatron PY, Janin A, Robert Y, Devulder B. Artérite digitale, thrombose et syndrome hyperéosinophilique: une complication exceptionnelle. Rev Med Int. 1996 ; 16 :434-6
- Robinowitz M, Virmani R, Mc Allister HA Jr. Spontaneous coronary artery dissection and eosinophilic inflammation: a cause and effect relationship? Am J Med.1982;72:923-8
- Ferguson GT, Starkebaum G. Thromboangiitis obliterans associated with idiopathic hypereosinophilia. Arch Intern Med.1985;145:1726-8
- Hamada T, Kimura Y, Hayashi Sh, Nakama T, Hashimoto T. Hypereosinophilic syndrome with peripheral circulatory insufficiency and cutaneous microthrombi. Arch dermatol. 2007;143:812-3
- Gleich GJ, Leiferman KM, Pardanai A, Tefferi A, Butterfield JH. Treatment of hypereosinophilis syndrome with imatinib mesilate. Lancet; 2002;359:1577-8
- Kuroyanagi Y, Kubo K, Matsui H, Kagami S, Mari S, Kim HJ et al. Manufacturing and banking system for allogeneic cultured dermal substitutes. Jpn J Burn Injuries.2003;29:28-38
- Takekawa M, Imai K, Adachi M, Aoki S, Maeda K, Hinoda Y et al. Hypereosinophilic syndrome accompanied with necrosis of finger tips. Intern Med. 1992;31:1262-6